Long Term Extension Study of Tapinarof for Plaque Psoriasis in Adults (3003)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
This is a long-term, open-label, multicenter, study to evaluate the safety and efficacy of topical tapinarof cream, 1% in adults with plaque psoriasis. Subjects in this study completed treatment in 1 of 2 Phase 3 pivotal efficacy and safety studies (Study DMVT-505-3001 or Study DMVT-505-3002). This study will consist of up to 40 weeks of treatment and a 4-week safety follow-up period.
Epistemonikos ID: c28c9c0545418ee4de492be9668d7e1c67fc67d7
First added on: May 22, 2024